Oxygenta Pharmaceutical Ltd — Important, 15-04-2026: Company Update

Oxygenta Pharmaceutical has confirmed compliance with Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended 31st March. The company certified that details of dematerialized securities were provided to all stock exchanges where its shares are listed. Its Registrar and Share Transfer Agent (RTA) confirmed that shares received for dematerialization were verified, mutilated, and cancelled, with depository records updated within 15 days. This ensures proper record-keeping for electronically held shares, reflecting robust operational compliance and investor protection in share transfers.